002826.SZ
Tibet Aim Pharm., Inc.
SZSE · Healthcare · C 制造业 · CN
CNY 17.07
−1.56%Margins
Gross margin
82.7%
EBITDA margin
17.9%
EBIT margin
15.6%
Net margin
13.9%
FCF margin
24.4%
11.1%
Return on equity
8.5%
Return on assets
—
Return on invested capital
0.63x
Asset turnover
CNY 172.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026